• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JCI Insight . Innate immune activation and mitochondrial ROS induce acute and persistent cardiac conduction system dysfunction after COVID-19

tetano

Editor, Senior Moderator
JCI Insight


. 2025 Dec 22;10(24):e193164.
doi: 10.1172/jci.insight.193164. Innate immune activation and mitochondrial ROS induce acute and persistent cardiac conduction system dysfunction after COVID-19

Deepthi Ashok[SUP] 1 [/SUP], Ting Liu[SUP] 1 [/SUP], Misato Nakanishi-Koakutsu[SUP] 2 3 [/SUP], Joseph Criscione[SUP] 4 [/SUP], Meghana Prakash[SUP] 1 [/SUP], Alexis Tensfeldt[SUP] 1 4 [/SUP], Byunggik Kim[SUP] 5 [/SUP], Bryan Ho[SUP] 4 [/SUP], Julian Chow[SUP] 6 [/SUP], Morgan Craney[SUP] 7 [/SUP], Mark J Ranek[SUP] 1 [/SUP], Brian L Lin[SUP] 1 [/SUP], Kyriakos Papanicolaou[SUP] 1 [/SUP], Agnieszka Sidor[SUP] 1 [/SUP], D Brian Foster[SUP] 1 [/SUP], Hee Cheol Cho[SUP] 2 3 [/SUP], Andrew Pekosz[SUP] 8 [/SUP], Jason Villano[SUP] 7 9 [/SUP], Deok-Ho Kim[SUP] 1 4 10 [/SUP], Brian O'Rourke[SUP] 1 4 10 [/SUP]



Affiliations
Abstract

Cardiac arrhythmias increase during acute SARS-CoV-2 infection and in long COVID syndrome, by unknown mechanisms. This study explored the acute and long-term effects of COVID-19 on cardiac electrophysiology and the cardiac conduction system (CCS) in a hamster model. Electrocardiograms and subpleural pressures were recorded by telemetry for 4 weeks after SARS-CoV-2 infection, and interferon-stimulated gene expression and macrophage infiltration of the CCS were assessed at 4 days and 4 weeks postinfection. COVID-19 induced pronounced tachypnea and cardiac arrhythmias, including bradycardia and persistent atrioventricular block, though no viral protein expression was detected in the heart. Arrhythmias developed rapidly, partially reversed, and then redeveloped, indicating persistent CCS injury. COVID-19 induced cardiac cytokine expression, connexin mislocalization, and CCS macrophage remodeling. Interestingly, sterile innate immune activation by direct cardiac injection of polyinosinic:polycytidylic acid (PIC) induced arrhythmias similar to those of COVID-19. PIC strongly induced cytokine secretion and interferon signaling in hearts, human induced pluripotent stem cell-derived cardiomyocytes, and engineered heart tissues, accompanied by alterations in excitation-contraction coupling. Importantly, the pulmonary and cardiac effects of COVID-19 were blunted by JAK/STAT inhibition or a mitochondrially targeted antioxidant, indicating that SARS-CoV-2 infection indirectly leads to arrhythmias by innate immune activation and redox stress, which could have implications for long COVID syndrome.

Keywords: Arrhythmias; Cardiology; Immunology; Infectious disease; Innate immunity; Mitochondria.

 
Back
Top